Company performance
Add to research
Current Price
as of Jun 18, 2025$1.75
P/E Ratio
N/A
Market Cap
$55.45M
Description
Add to research
Talis Biomedical Corp. develops and commercializes innovative products that are designed to enable accurate, reliable, low cost and rapid molecular testing for infectious diseases. The company was founded on June 26, 2013 and is headquartered in Chicago, IL.
Metrics
Add to research
Overview
- HQChicago, IL
- SectorHealth Technology
- IndustryMedical Specialties
- TickerTLIS
- Price$1.75+24.11%
Trading Information
- Market cap$55.45M
- Float5.28%
- Average Daily Volume (1m)829
- Average Daily Volume (3m)577
- EPS-$28.02
Company
- Revenue$0.30M
- Rev growth (1yr)-100.00%
- Net income-$8.85M
- Gross marginN/A
- EBITDA marginN/A
- EBITDA-$8.49M
- EV-$25.28M
- EV/Revenue-84.26
- P/EN/A
- P/S10.63
- P/B1.14
- Debt/Equity38.66
Documents
Add to research
SEC Filings